Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for prevention and restoration of cognitive dysfunction in high grade glioma receiving radiotherapy with hyperbaric oxygenation
jRCTs071190010Phase 3Recruiting
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of memantine in malignant glioma (3 arms). Primary endpoints: Hippocampal function and Higher brain function. Started Jun 2018; status: recruiting.
02
Drugs
memantine
03
Conditions
malignant glioma
Beyond the preview
Go deeper on jRCTs071190010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190010.